The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Authors
Haviland, J
Owen, J
Dewar, J
Agrawal, R
Barrett, J
Barrett-Lee, P
Dobbs, H
Hopwood, P
Lawton, P
Magee, Brian
Mills, J
Simmons, S
Sydenham, M
Venables, K
Bliss, J
Yarnold, J
Affiliation
ICR-CTSU, Division of Clinical Studies, The Institute of Cancer Research, Sutton, UK; University of Southampton Clinical Trials Unit, Southampton, UK.
Issue Date
2013-10

Metadata
Show full item record
Abstract
5-year results of the UK Standardisation of Breast Radiotherapy (START) trials suggested that lower total doses of radiotherapy delivered in fewer, larger doses (fractions) are at least as safe and effective as the historical standard regimen (50 Gy in 25 fractions) for women after primary surgery for early breast cancer. In this prespecified analysis, we report the 10-year follow-up of the START trials testing 13 fraction and 15 fraction regimens.
Citation
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. 2013, 14 (11):1086-94 Lancet Oncol
Journal
The Lancet Oncology
URI
http://hdl.handle.net/10541/308810
DOI
10.1016/S1470-2045(13)70386-3
PubMed ID
24055415
Type
Article
Language
en
ISSN
1474-5488
Collections